deltatrials
Unknown PHASE1 INTERVENTIONAL 3-arm NCT03129139

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (Minnelide 101)

Sponsor: Minneamrita Therapeutics LLC

Conditions Advanced Cancer Breast Cancer Cancer of Stomach Colo-rectal Cancer Gastric Cancer Pancreatic Cancer Prostate Cancer Metastatic Solid Carcinoma Solid Carcinoma of Stomach Solid Tumor
Interventions Minnelide™Capsules
Updated 16 times since 2017 Last updated: Oct 17, 2023 Started: Oct 10, 2017 Primary completion: Jun 1, 2024 Completion: Dec 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Advanced Cancer and Breast Cancer, this trial is ongoing. The trial is conducted by Minneamrita Therapeutics LLC and has accumulated 16 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jun 2017 – ~Nov 2017 · 5 months · monthly snapshot~Nov 2017 – ~Mar 2018 · 4 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~Aug 2019 · 4 months · monthly snapshot~Aug 2019 – ~Jan 2020 · 5 months · monthly snapshot~Jan 2020 – ~May 2020 · 4 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~May 2022 · 12 months · monthly snapshot~May 2022 – ~Nov 2023 · 18 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2025 · 14 months · monthly snapshot~Nov 2025 – present · 8 months · monthly snapshot

Change History

16 versions recorded

  1. Nov 2025 — Present [monthly]

    Unknown PHASE1

    Status: Recruiting → Unknown

  2. Sep 2024 — Nov 2025 [monthly]

    Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  4. Nov 2023 — Jul 2024 [monthly]

    Recruiting PHASE1

  5. May 2022 — Nov 2023 [monthly]

    Recruiting PHASE1

▶ Show 11 earlier versions

  1. May 2021 — May 2022 [monthly]

    Recruiting PHASE1

  2. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE1

  3. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE1

  4. May 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  5. Jan 2020 — May 2020 [monthly]

    Recruiting PHASE1

  6. Aug 2019 — Jan 2020 [monthly]

    Recruiting PHASE1

  7. Apr 2019 — Aug 2019 [monthly]

    Recruiting PHASE1

  8. Jun 2018 — Apr 2019 [monthly]

    Recruiting PHASE1

  9. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

  10. Nov 2017 — Mar 2018 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  11. Jun 2017 — Nov 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Minneamrita Therapeutics LLC
  • Translational Drug Development
Data source: Minneamrita Therapeutics LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations